Gelişmiş Arama

Basit öğe kaydını göster

dc.contributor.authorTapan, Tuba Kayan
dc.contributor.authorCelebi, Filiz
dc.contributor.authorYaghouti, Kourosh
dc.contributor.authorAgacayak, Filiz
dc.contributor.authorIlgun, Serkan
dc.contributor.authorSoybir, Guersel
dc.contributor.authorAlco, Gul
dc.date.accessioned2025-01-12T18:54:44Z
dc.date.available2025-01-12T18:54:44Z
dc.date.issued2024
dc.identifier.issn2587-0831
dc.identifier.urihttps://doi.org/10.4274/ejbh.galenos.2024.2023-12-5
dc.identifier.urihttp://hdl.handle.net/11446/4957
dc.description.abstractObjective: Differences in individual muscle/fat volumes may change the effectiveness of chemotherapy. In this study, the relationship between trunkal muscle and fat volume and body mass index (BMI) obtained before receiving neoadjuvant chemotherapy (NCT) in patients with breast cancer and complete pathological response (pCR) was investigated. Materials and Methods: The volumes of psoas, abdominal and paraspinal muscles, and trunkal subcutaneous and visceral fat were calculated using CoreSlicer AI 2.0 opensource program from the F-18 fluorodeoxyglucose positron emission tomography/computed tomography (CT) and CT images before NCT and postoperative pCR rates to NCT were recorded. Muscle/fat volumes and BMI prior to NCT were compared in terms of pathological pCR rates. Patients were followed up regularly for recurrence and survival. Results: Ninety-three patients were included with median (range) values for age, BMI, and body weights of 48 (28-72) years, 27 (16.8-51.6) kg/m(2), and 71.94 (43-137) kg, respectively. The median follow-up time was 18.6 (6.7-59.6) months. No significant correlation was found between total muscle or fat volumes of patients with and without pCR. BMI [26.2 (16.8-51.6) kg/m(2) vs. 24.6 (20.3-34.3) kg/m(2), p = 0.03] and pCR rates in patients with low rightpsoas muscle volume [11.74 (7.03-18.51) vs. 10.2 (6.71-13.36), p = 0.025] were significantly greater. A significant relationship was found between right psoas muscle volume and disease-free survival (DFS) (11.74 cm(3) (7.03-18.51) vs. 10.2 cm(3) (6.71-13.36), p = 0.025). However, no significant relationship was detected between total muscle-fat volume, BMI and overall survival and DFS (p>0.05). Conclusion: This is the first published study investigating the relationship between the pCR ratio and body muscle and fat volume measured by CoreSlicer AI 2.0 in patients with breast cancer who received NCT. No correlation was found between the pCR ratio and total muscle plus fat volume. However, these results need to be validated with larger patient series.en_US
dc.language.isoengen_US
dc.publisherGalenos Publ Houseen_US
dc.relation.ispartofEuropean Journal of Breast Healthen_US
dc.identifier.doi10.4274/ejbh.galenos.2024.2023-12-5
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectBreast canceren_US
dc.subjectFDG-PET-CTen_US
dc.subjectpCRen_US
dc.subjecttotal muscle-fat volumeen_US
dc.subjectBMIen_US
dc.subjectneoadjuvant chemotherapyen_US
dc.subjectBody-Mass Indexen_US
dc.subjectSurvivalen_US
dc.subjectObesityen_US
dc.subjectWeighten_US
dc.subjectImpacten_US
dc.titleThe Relationship of Pathological Response and Visceral Muscle and Fat Volume in Women With Breast Cancer Who Received Neoadjuvant Chemotherapyen_US
dc.typearticleen_US
dc.departmentDBÜen_US
dc.identifier.issue2en_US
dc.identifier.volume20en_US
dc.identifier.startpage117en_US
dc.identifier.endpage121en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.department-temp[Tapan, Tuba Kayan] Demiroglu Bilim Univ, Fac Hlth Sci, Dept Nutr & Dietet, Istanbul, Turkiye; [Celebi, Filiz] Yeditepe Univ, Fac Med, Dept Radiol, Istanbul, Turkiye; [Yaghouti, Kourosh] Gayrettepe Florance Nightingale Hosp, Clin Radiol, Istanbul, Turkiye; [Agacayak, Filiz] Istanbul Florance Nightingale Hosp, Clin Radiol, Istanbul, Turkiye; [Ilgun, Serkan] Mater Dei Hosp, Clin Breast Surg, Cent Reg, Msida, Malta; [Soybir, Guersel] Sisli Mem Hosp, Clin Gen Surg, Istanbul, Turkiye; [Alco, Gul] Gayrettepe Florance Nightingale Hosp, Clin Radiat Oncol, Istanbul, Turkiye; [Ak, Naziye; Ordu, Cetin] Gayrettepe Florance Nightingale Hosp, Clin Oncol, Istanbul, Turkiye; [Ozkurt, Enver] Istanbul Florance Nightingale Hosp, Clin Breast Surg, Istanbul, Turkiye; [Unal, Caglar] Kartal Dr Lutfi Kirdar City Hosp, Clin Oncol, Istanbul, Turkiye; [Kurt, Sevgi] Gayrettepe Florance Nightingale Hosp, Clin Plast Surg, Istanbul, Turkiye; [Ozturk, Alper] Biruni Univ Hosp, Fac Med, Dept Gen Surg, Biruni Univ, Istanbul, Turkiye; [Iyigun, Zeynep] Bahcesehir Univ, Goztepe Med Park Hosp, Fac Med, Dept Phys Therapy & Rehabil, Istanbul, Turkiye; [Duymaz, Tomris] Istanbul Bilgi Univ, Fac Hlth Sci, Dept Phys Therapy & Rehabil, Istanbul, Turkiye; [Ozmen, Vahit] Istanben_US
dc.authoridAk, Naziye/0000-0001-5790-7066
dc.authoridOrdu, Cetin/0000-0003-4423-8005
dc.authoridOzkurt, Enver/0000-0003-2597-3119
dc.authoridALCO, GUL/0000-0002-3592-9923
dc.authoridCelebi, Filiz/0000-0003-4020-4019
dc.authoridKayan Tapan, Tuba/0000-0001-6287-5601
dc.identifier.pmid38571683en_US
dc.identifier.scopus2-s2.0-85191318043en_US
dc.identifier.wosWOS:001221178600006en_US
dc.authorwosidAk, Naziye/AAP-3920-2020
dc.authorwosidALCO, GUL/B-7990-2016
dc.authorscopusid56613471000
dc.authorscopusid56522791700
dc.authorscopusid57210288465
dc.authorscopusid35268079300
dc.authorscopusid57200631980
dc.authorscopusid35608451600
dc.authorscopusid35095972600
dc.identifier.trdizinid1264972en_US


Bu öğenin dosyaları:

DosyalarBoyutBiçimGöster

Bu öğe ile ilişkili dosya yok.

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster